{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03510",
    "Peptide Name": "Lt-MAP2 (Lys-rich; Leu-rich; synthetic AMPs20, UCLL1a)",
    "Source": "derivatives of Latarcin-3a",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "LIKKLKEYLKKLI",
    "Sequence Length": 13,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antibiofilm",
      "Anticancer"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 4,
    "Boman Index": 0.39,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "46%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals this sequence is most similar (76.92%) toLt-MAP1L: 31%; K: 38%; I: 15%; E=Y=8%. GRAVY: -0.00769; Mol Wt: 1630.117; Mol formula: C80H144N18O17; Mol ex coeff: 1490.Activity: Active against Gram- A. baumannii ATCC 003321216 (MIC 8 ug/ml), E.coli ATCC 25922 (MIC >128 ug/ml), K. pneumoniae ATCC 13883 (MIC 32-64 ug/ml), P.aeruginosa KPC+ 003321199 (MIC >128 ug/ml), Gram+ P. acnes ATCC 51277 (MIC 64 ug/ml) and S.aureus ATCC 7133623 (MIC > 128 ug/ml).  It also inhibits biofilm formation against A. baumannii ATCC 003321216 (MBIC 32 ug/ml) and E. coli ATCC 25922 (MBIC 16 ug/ml). It also inhibited C1498, Kasumi-1 and K562 cancer cell lines. Deposited and provided by Felipe Nunes 12/2022.",
    "Author": "de Moraes LFRN, Silva PS, Pereira TCPL, Almeida Rodrigues TA, Farias Frihling BE, da Costa RA, Torquato HFV, Lima CS, Paredes-Gamero EJ and Migliolo L 2022",
    "Reference": "Front. Microbiol. 13:965621. doi: 10.3389/fmicb.2022.965621.Frontiers Microbiol",
    "Title": "First generation of multifunctional peptides derived from latarcin-3a from Lachesana tarabaevi spider toxin"
  },
  "3D Structure": []
}